Wastewater treatment expert: +86-181-0655-2851 Get Expert Consultation
HYDROPUREWATER · Industry library

Pharmaceutical wastewater
A connected industry library.

Trace production, cleaning and concentrated side-streams separately. Connect each to its pollutants, treatment conditions and original technical references.

Country coverage & industry connections

Country links count catalog associations, not verified plants or proof that every sub-industry operates there. The right-hand branches are industry references.

Explore the full database →
Country libraryProduction. Water. Treatment.Pharmaceutical ManufacturingUnited States · 38United States · 38India · 5India · 5Germany · 3Germany · 3Malaysia · 3Malaysia · 3Mexico · 3Mexico · 3Vietnam · 3Vietnam · 3Chemical API synthesisChemical API synthesisFermentation & biotechnologyFermentation &biotechnologyMixing & formulationMixing & formulationEquipment cleaningEquipment cleaningConcentrates & residualsConcentrates & residuals
Country links count catalog associations, not verified plants or proof that every sub-industry operates there. The right-hand branches are industry references.
Browse all country libraries
United States38India5Germany3Malaysia3Mexico3Vietnam3Bangladesh2Algeria1Angola1Argentina1Australia1Azerbaijan1Bahrain1Brazil1Cambodia1Cameroon1Chile1China1Colombia1Costa Rica1Denmark1Dominican Republic1Ecuador1Egypt1Ethiopia1France1Ghana1Indonesia1Iran1Iraq1Italy1Ivory Coast1Japan1Jordan1Kazakhstan1Kenya1Morocco1Mozambique1Myanmar1Nepal1Nigeria1Oman1Panama1Peru1Philippines1Poland1Qatar1Russia1Rwanda1Saudi Arabia1Senegal1Singapore1South Africa1Spain1Sweden1Tanzania1Thailand1Turkey1Turkmenistan1Uganda1United Arab Emirates1United Kingdom1Uzbekistan1Pakistan0

Production. Water. Treatment.

Choose a branch, then select a connection. Read what supports it, when it applies and where it stops.

Mother liquors and wash waters need separate characterisation.

Production streamWater challengeTreatment / controlSynthesis mother liquorSynthesis mother liquorSolvents & concentrated organicsSolvents & concentratedorganicsSegregate for recoverySegregate for recoveryPretreated synthesis waterPretreated synthesiswaterResidual API & refractory compoundsResidual API &refractory compoundsTest targeted polishingTest targeted polishing
All documented connections
Production streamWater challengeTreatment / controlWhen it applies
Chemical API synthesis · Synthesis mother liquorSolvents & concentrated organicsSegregate for recovery

Assess solvent recovery before combining with dilute effluent.

Identify composition, compatibility and safe residual handling.

Recovery does not establish removal of the active ingredient.

IFC / World Bank Group US Environmental Protection Agency
Chemical API synthesis · Pretreated synthesis waterResidual API & refractory compoundsTest targeted polishing

Assess adsorption or oxidation against the identified compounds.

Verify the actual target and treatment by-products.

Low bulk COD does not prove absence of active compounds.

IFC / World Bank Group World Health Organization
Fermentation & biotechnology · Spent fermentation brothBiodegradable load & nitrogenAssess biological treatment

Test the pretreated stream for organic and nitrogen treatment.

Check inhibition, batch variation and residual antibiotics.

Biodegradable broth is not proof of antibiotic removal.

US Environmental Protection Agency World Health Organization
Fermentation & biotechnology · Biological culture effluentBiological containment dutyValidate inactivation if needed

Assess containment and inactivation before ordinary treatment.

Base the procedure on the actual organism and biohazard.

An ordinary filter is not validated biological inactivation.

IFC / World Bank Group
Mixing & formulation · Mixing & product transferProduct & excipient lossesPrevent & segregate losses

Examine product recovery and first-rinse collection at source.

Keep recovery compatible with product-quality requirements.

A formulation category does not define one fixed wastewater quality.

US Environmental Protection Agency US Environmental Protection Agency
Mixing & formulation · Antibiotic product rinsingAntibiotic pollution riskAssess compound-specific controls

Include antibiotic pollution in the manufacturing risk assessment.

Identify the antibiotic and a defensible monitoring target.

Conventional indicators alone do not establish antibiotic safety.

World Health Organization
Equipment cleaning · Acid / alkali cleaningpH & cleaning-chemical peaksSeparate, balance & adjust pH

Meter suitable reagents after characterising the cleaning cycle.

Confirm compatibility before any mixing.

A neutral pH does not establish API or disinfectant removal.

IFC / World Bank Group IFC / World Bank Group
Equipment cleaning · Campaign changeover washIntermittent concentrated lossesReduce & collect at source

Assess cleaning losses and keep concentrated fractions identifiable.

Retain validated cleaning and product-quality requirements.

Waste reduction must not compromise manufacturing hygiene.

US Environmental Protection Agency US Environmental Protection Agency
Concentrates & residuals · Saline process liquorDissolved salts & residual compoundsAssess separate concentrate route

Evaluate salt separation alongside concentrate management.

Check scaling, organics and safe residual disposal.

An MBR is not a desalination or universal API barrier.

IFC / World Bank Group IFC / World Bank Group
Concentrates & residuals · Treatment sludgeWater & retained pollutantsCharacterise & dewater

Dewater residuals within a characterised waste-management route.

Confirm cake classification and return-filtrate treatment.

Dewatering does not destroy retained pharmaceutical compounds.

IFC / World Bank Group IFC / World Bank Group

Equipment in context

Equipment follows the treatment duty. Flow, solids, fats, biodegradability and the receiving route still require a site assessment.

Original references

Industry reference, not local sampling, a national discharge limit or validated API removal. Determine the product, compounds, biological hazards, discharge route and permit before selecting a treatment train.

Technical references reviewed

EHS Guidelines for Pharmaceuticals and Biotechnology Manufacturing

IFC / World Bank Group · 1.1 Environment — Industrial Process Wastewater; Process Wastewater Treatment; Annex A · Printed page 4–5, 18–20

GIIP reference for API and secondary pharmaceutical manufacturing. Additional controls depend on the actual active compounds, toxicity and site conditions.

especially those associated with active ingredients
Read original source ↗
Development Document for Final Effluent Limitations Guidelines and Standards for the Pharmaceutical Manufacturing Point Source Category

US Environmental Protection Agency · 3.4.2 General Process Descriptions; 8.3 Treatment Technology Performance · Printed page 3-29–3-38; 8-5–8-11

Historical US technical development document used for process distinctions and treatment principles, not current permit limits for other jurisdictions or a universal performance claim.

specific processing steps on individual process lines may differ
Read original source ↗
Pharmaceutical Manufacturing Effluent Guidelines

US Environmental Protection Agency · Facilities Covered; Guidance and Analytical Methods Documents · Printed page Web sections

US regulatory category reference showing fermentation, extraction, synthesis, formulation and research as distinct operations. No US limits are assigned to another country.

Mixing/Compounding and Formulation
Read original source ↗
Guidance on wastewater and solid waste management for manufacturing of antibiotics

World Health Organization · Overview; scope of the 2024 guidance · Printed page Publication overview

WHO guidance overview on antibiotic manufacturing pollution, antimicrobial resistance and risk management. No numeric antibiotic targets are copied here; compound-specific evaluation is required.

Pollution contributes to antibiotic resistance
Read original source ↗
Guides to Pollution Prevention: The Pharmaceutical Industry

US Environmental Protection Agency · 3. Waste Minimization Options for Pharmaceutical Facilities — Source Reduction; Recovery and Recycle · Printed page 11–14

Historical advisory source-reduction reference. It supports examining recovery and cleaning losses, not selecting a modern discharge limit or certifying a process.

source reduction and recycling
Read original source ↗
General EHS Guidelines — Wastewater and Ambient Water Quality

IFC / World Bank Group · 1.3 Wastewater Management; Industrial Wastewater; Monitoring; Annex 1.3.1 · Printed page 25–32

Cross-industry technical reference for stream separation, treatment and monitoring. Confirm current national requirements and the actual receiving route separately.

quality, quantity, frequency and sources
Read original source ↗

Questions before selecting a treatment

Why separate API synthesis from formulation?

Their operations and waste streams differ. Use the actual process, product and cleaning cycle to define the sampling plan.

Does meeting COD prove antibiotic removal?

No. Assess the relevant antibiotic separately and establish a suitable monitoring target; bulk organic indicators alone cannot demonstrate it.

Can MBR alone treat every pharmaceutical effluent?

No universal assignment is made here. Test toxicity and biodegradability, then consider salts, active compounds and residuals as separate duties.

Do these references supply my local discharge limits?

No. Confirm the country, receiving sewer or water body, current permit and compound-specific requirements before selecting compliance targets.

What information should a pharmaceutical enquiry include?

Provide the production route, flow profile, separate cleaning streams, known compounds and analyses. Include toxicity, salinity, biological hazards and the proposed outlet where relevant.

Bring your process into the picture.

Share your country, production stream and available water analysis to assess a suitable treatment train.

Discuss your wastewater →

Pharmaceutical Manufacturing — water evidence database

Public guides, reported developments and reviewed evidence. Counts describe this library’s coverage.

Explore relationships
Partial: confirmed material onlyPartial coveragePublic snapshot · UTC+8

Related guides
194
Reported events
0
Reviewed facts
12
Published dossiers
1
Independent sources
1

Guides are article candidates, events are source-supported reports, and facts are reviewed records. Countries and industries overlap; grouped counts cannot be added into a global total.

Country × industry coverage

Select a cell to inspect its records. Coverage measures published material, never market size, factories or local project volume.

Related guides · more published material
Select a cell to inspect its records. Coverage measures published material, never market size, factories or local project volume.
CountryTextileFood & BeverageChemical ManufacturingPharmaceutical ManufacturingOil & GasMunicipal Wastewater
Algeria13—116
Angola33—115
Argentina1511—5
Australia24—1121
Azerbaijan———1——
Bahrain1111—6
Bangladesh101—2—5
Bolivia1—————
Brazil1511119
Burkina Faso—1————
Cambodia22—1—6
Cameroon23—1—4
Canada252——27
Chile13—1—6
China5111—1
Colombia14—1—7
Costa Rica11—1—2
Cyprus—————1
Czech Republic—1———2
Denmark—2—1—1
Dominican Republic2211—4
Ecuador1321—5
Egypt420108
El Salvador—————1
Ethiopia33—1—1
Fiji—1———1
Finland—1———1
France1311—8
Germany13—3—7
Ghana23—1—6
Greece—1———1
Hungary—2————
India341745—51
Indonesia11641—15
Iran645118
Iraq131128
Ireland—3———2
Israel11———5
Italy13—1—4
Ivory Coast11—1—4
Japan1111—1
Jordan21—1—6
Kazakhstan11—115
Kenya43—113
Kuwait133—27
Lebanon————1—
Malaysia16—3—16
Mexico4513—17
Mongolia11———1
Montenegro—1————
Morocco6311—9
Mozambique31—1—6
Myanmar2111—5
Namibia—————1
Nepal32—1—1
Netherlands12———2
New Zealand—2———2
Nigeria553117
Norway11———2
Oman223136
Pakistan12330—12
Panama342115
Peru54—1—6
Philippines3321—14
Poland11—1—3
Portugal12———1
Qatar2321—6
Romania—1———2
Russia—211—1
Rwanda2211—3
Saudi Arabia1741215
Senegal2111—4
Singapore11—1—2
South Africa23—1—13
South Korea21———5
Spain13—1—3
Sri Lanka321——2
Sweden11—1—1
Syria—————1
Tajikistan—————1
Tanzania14—1—1
Thailand47—1—10
Turkey4211—1
Turkmenistan31—1—3
Uganda55—1—5
Ukraine—————1
United Arab Emirates232119
United Kingdom1311—20
United States212984213824864
Uzbekistan41—1—4
Vietnam5313—13

A dash means coverage is unknown or unconnected. A verified zero is shown only when the metric scope is known.

Daily public additions

First verified public appearance in this library, by UTC+8 day. Source publication dates do not create historical growth.

Reported eventsReviewed factsPublished dossiersRelated guides
—
—
—
—
—
—
—
—
—
—
—
—

History is accumulating. Missing or failed days remain gaps; a single snapshot cannot establish a trend. Historical baseline and backfill are labelled separately.

Inspect recorded days and changes
Day (UTC+8)Coverage statusnew recordsHistorical backfillRevisedWithdrawnRestored
2026-10-15Partial: confirmed material only—0000
2026-10-16Partial: confirmed material only10000
2026-10-17Partial: confirmed material only20000
2026-10-18Partial: confirmed material only10000
2026-10-19Partial: confirmed material only—0000
2026-10-20Partial: confirmed material only—0000
2026-10-21Partial: confirmed material only10000
2026-10-22Partial: confirmed material only10000
2026-10-23Partial: confirmed material only10000
2026-10-24Partial: confirmed material only—0000
2026-10-25Partial: confirmed material only10000
2026-10-26Partial: confirmed material only—0100
2026-10-27Partial: confirmed material only—0000
2026-10-28Partial: confirmed material only30000
2026-10-29Partial: confirmed material only20000
2026-10-30Partial: confirmed material only10000
2026-10-31Partial: confirmed material only10000
2026-11-01Partial: confirmed material only—0000
2026-11-02Partial: confirmed material only—0000
2026-11-03Partial: confirmed material only10000
2026-11-04Partial: confirmed material only—0000
2026-11-05Partial: confirmed material only20000
2026-11-06Partial: confirmed material only20000
2026-11-07Partial: confirmed material only—0000
2026-11-08Partial: confirmed material only10000
2026-11-09Partial: confirmed material only30000
2026-11-10Partial: confirmed material only—0000
2026-11-11Partial: confirmed material only—0000
2026-11-12Partial: confirmed material only10000
2026-11-13Partial: confirmed material only—0000
2026-11-14Partial: confirmed material only—0000
2026-11-15Partial: confirmed material only10000
2026-11-16Partial: confirmed material only—0000
2026-11-17Partial: confirmed material only10000
2026-11-18Partial: confirmed material only150000
2026-11-19Partial: confirmed material only10000
2026-11-20Partial: confirmed material only20000
2026-11-21Partial: confirmed material only10000
2026-11-22Partial: confirmed material only10000
2026-11-23Partial: confirmed material only—0000

Current sources and reviewed facts

Two separate stocks at the published watermark. No historical stock line is reconstructed from article dates.

Current snapshot only
Independent sources1
Reviewed facts12

Record explorer

Inspect the records behind the selected coverage or day. Source links open the original publisher.

Record typeRecordCountryFirst public verificationEvidence
Guide candidateMBR vs Activated Sludge for Greenville Pharmaceutical WastewaterEnglish source titleUnited States2026-11-22 15:19Open the record for its evidence
Guide candidatePharmaceutical Wastewater Treatment in France: MBR Selection GuideEnglish source titleFrance2026-11-21 15:32Open the record for its evidence
Guide candidatePharmaceutical Wastewater Treatment in Costa Rica: 2026 GuideEnglish source titleCosta Rica2026-11-20 15:24Open the record for its evidence
Guide candidateMBR vs Activated Sludge for Chattanooga Pharmaceutical WastewaterEnglish source titleUnited States2026-11-20 15:24Open the record for its evidence
Guide candidateBelt Filter Presses for Pharmaceutical Wastewater: Selection GuideEnglish source titleCountry scope not reported2026-11-19 15:35Open the record for its evidence
Guide candidatePharmaceutical Wastewater Treatment in the Dominican RepublicEnglish source titleDominican Republic2026-11-18 16:36Open the record for its evidence
Guide candidatePharmaceutical Wastewater Treatment in Germany: 2026 GuideEnglish source titleGermany2026-11-18 16:36Open the record for its evidence
Guide candidateDAF vs. Clarifier for Pharma Wastewater in Cincinnati: 2026English source titleUnited States2026-11-17 14:46Open the record for its evidence
Guide candidatePharmaceutical Wastewater Treatment in Panama: 2026 GuideEnglish source titlePanama2026-11-15 14:40Open the record for its evidence
Guide candidatePAC Dosing Systems for Pharmaceutical Wastewater: 2026 GuideEnglish source titleCountry scope not reported2026-11-12 14:40Open the record for its evidence
Guide candidateWhat ETP Does Novartis Need After Expanding Its Pharma Plant? 2026English source titleCountry scope not reported2026-11-09 14:38Open the record for its evidence
Guide candidateHow Do Pharma Plants Near Alachua Meet Sewer Limits?English source titleUnited States2026-11-09 14:38Open the record for its evidence

Related guides

Technical and news articles provide reading paths and candidate associations; they do not prove a local project or reviewed fact.

More country-specific reading is available through the country links in the coverage table.

Recent reported developments

Source publication and first public verification are separate dates. Reported developments remain observations.

No source-supported events are public for this selection.

Comparable water samples

Compare only matching parameter, unit, water stage and scope. Individual facility samples never represent a national average or a continuous water-quality trend.

No group of at least two comparable, reviewed samples is available. Read individual evidence in the published dossiers.

Move from evidence to a treatment discussion

Carry the selected country and industry into your enquiry. Confirm influent conditions, discharge destination and operating scope with the engineering team.

Snapshot scope and provenance
Version
86bf514f9965e134c11a5da6fa74714e460d9fa664973e377ff05f8dd3b34bad
Industry classification version
2026-10-15.1
Reviewed foundation version
20261015T105811-e19facf957c3
Observation version
ec4063e1203c11f4cde1b0b0cd605ff1e4a88de125a6bddfeabba96dafe156a0
Public coverage watermark
b13e9e980ea1373beb87c0d4c5b5337690ad0b30d73553a4a0e8129d8ec1d961
Historical baseline cutoff
Not reported

Only caller-frozen public records are counted. Language versions and revisions share a record identity; source versions share the independent source identity.

AI Growth
Contact
Contact Us
Call Us
+86-181-0655-2851
Email Us Get a Quote Contact Us